(Q44401173)

2 December 2017

The absence of functional glucosylceramide synthase does not sensitize melanoma cells for anticancer drugs (English)

1 reference

antineoplastic resistance

2 December 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692077

23 December 2023

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

23 December 2023

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

23 December 2023

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

23 December 2023

1

Robert Jan Veldman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692077

23 December 2023

4

Virginie Garcia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692077

23 December 2023

author name string

Alain Mita

2

1 reference

2 December 2017

Olivier Cuvillier

3

1 reference

2 December 2017

Karin Klappe

5

1 reference

2 December 2017

Stéphane Carpentier

8

1 reference

2 December 2017

Jan Willem Kok

9

1 reference

2 December 2017

Thierry Levade

10

1 reference

2 December 2017

Jeffrey A. Medin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692077

23 December 2023

John D. Campbell

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692077

23 December 2023

language of work or name

English

0 references

publication date

8 April 2003

1 reference

full work available at URL

2 December 2017

http://www.fasebj.org/cgi/content/abstract/17/9/1144

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692077

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.02-1053fje

23 December 2023

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

https://onlinelibrary.wiley.com/doi/full-xml/10.1096/fj.02-1053fje

23 December 2023

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

23 December 2023

1 reference

2 December 2017

17

1 reference

2 December 2017

9

1 reference

2 December 2017

1144-1146

1 reference

Biochemistry of multidrug resistance mediated by the multidrug transporter

2 December 2017

1

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice

23 December 2023

4

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia

23 December 2023

5

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

BCL-X expression in multiple myeloma: possible indicator of chemoresistance

23 December 2023

7

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

23 December 2023

8

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Regulation of ceramide production and apoptosis

23 December 2023

9

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Signalling sphingomyelinases: which, where, how and why?

23 December 2023

10

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Ceramide in the eukaryotic stress response

23 December 2023

11

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals

23 December 2023

13

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis

23 December 2023

14

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

The topoisomerase inhibitors camptothecin and etoposide induce a CD95-independent apoptosis of activated peripheral lymphocytes

23 December 2023

15

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Accumulation of glucosylceramides in multidrug-resistant cancer cells

23 December 2023

16

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Differential expression of sphingolipids in MRP1 overexpressing HT29 cells

23 December 2023

17

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Glucosylceramide: a marker for multiple-drug resistant cancers

23 December 2023

18

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells

23 December 2023

19

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Ceramide glycosylation potentiates cellular multidrug resistance

23 December 2023

20

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance

23 December 2023

21

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells

23 December 2023

23

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

The involvement of sphingolipids in multidrug resistance

23 December 2023

24

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Melanoma antigen expression and metastatic ability of mutant B16 melanoma clones

23 December 2023

25

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

A mouse B16 melanoma mutant deficient in glycolipids

23 December 2023

26

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis

23 December 2023

27

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

A new collection method for the evaluation of nasal mucus proteins.

23 December 2023

28

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Sphingosine 1-phosphate inhibits activation of caspases that cleave poly(ADP-ribose) polymerase and lamins during Fas- and ceramide-mediated apoptosis in Jurkat T lymphocytes

23 December 2023

30

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Sphingosine generation, cytochrome c release, and activation of caspase-7 in doxorubicin-induced apoptosis of MCF7 breast adenocarcinoma cells.

23 December 2023

31

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Expression of P-glycoprotein and multidrug resistance associated protein in Ehrlich ascites tumor cells after fractionated irradiation.

23 December 2023

32

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis

23 December 2023

33

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Mitochondria as the central control point of apoptosis

23 December 2023

34

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Glucosylceramide synthase does not attenuate the ceramide pool accumulating during apoptosis induced by CD95 or anti-cancer regimens

23 December 2023

35

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Positive feedback control of neutral sphingomyelinase activity by ceramide.

23 December 2023

37

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Tumor necrosis factor induces ceramide oscillations and negatively controls sphingolipid synthases by caspases in apoptotic Kym-1 cells

23 December 2023

38

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

ABC transporters in lipid transport

23 December 2023

40

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Sphingolipid transport in eukaryotic cells.

23 December 2023

41

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Characterisation of adriamycin- and amsacrine-resistant human leukaemic T cell lines

23 December 2023

42

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

Altered sphingolipid metabolism in multidrug-resistant ovarian cancer cells is due to uncoupling of glycolipid biosynthesis in the Golgi apparatus.

23 December 2023

44

1 reference

https://api.crossref.org/works/10.1096/FJ.02-1053FJE

23 December 2023

Identifiers

0 references

1 reference